1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Regulation

California DTSC Releases Draft Alternatives Analysis Guide For Comment

 
• By Ryan Nelson

The Department of Toxic Substances Control issued draft guidance last September on the first stage of analyses required from responsible parties to identify alternatives to Priority Product chemicals under California’s Safer Consumer Products regs. Industry groups identified weaknesses in the document, but said they were holding out for complete guidance, which is now available and open for comment.

Nail-product manufacturers in particular should take note of the California Department of Toxic Substances Control’s draft Alternatives Analysis Guide, released earlier this month, with the “toxic trio” and other nail-care chemicals floated as possible targets for selection in the agency’s second round of Priority Products.

Priority Products – which identify a chemical of concern in a specific product class (e.g., paint stripper with methylene chloride,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

EPR-Impacted Producers: Budget Early, Consider Other State Programs Before Repackaging

 
• By Eileen Francis

Consultants urge packaging producers to forecast and budget now for the fees of state EPR programs, particularly as fees from the Oregon program hit and surprise many firms and expose gaps in internal budgeting and planning. The topic was discussed at IBA’s Cosmetics Convergence 2025 conference.

US FDA’s Delay of Cosmetic GMP Rule, Communication Style Raises Litigation Concerns – Attorneys

 
• By Eileen Francis

The US FDA’s decision to move its long-awaited cosmetic GMPs rule to ‘Long-Term Actions’ under MoCRA likely delays a final rule for at least five years, raising the risk of increased state regulation and private litigation, say attorneys speaking during the 2025 PCPC Science Symposium & Expo

‘You Are Very Regulated’: Consumer Health And Beauty Industries’ Attention Needed In California

 
• By Malcolm Spicer

Regulations likely holding consumer product firms’ attention include the Plastic Pollution Prevention and Packaging Producer Responsibility Act, SB 54, scheduled to become effective by 2027. “Easily the most significant, extended producer responsibility law ever to pass in the world,” says lobbyist

US FDA Independence Questioned At CDC Oversight Hearing

 
• By Michael McCaughan

A Senate committee is investigating leadership changes at the US Centers for Disease Control and Prevention. While the primary focus is vaccine policy, the first hearing suggested the probe could raise questions about FDA independence.

More from Policy & Regulation

US FDA’s Delay of Cosmetic GMP Rule, Communication Style Raises Litigation Concerns – Attorneys

 
• By Eileen Francis

The US FDA’s decision to move its long-awaited cosmetic GMPs rule to ‘Long-Term Actions’ under MoCRA likely delays a final rule for at least five years, raising the risk of increased state regulation and private litigation, say attorneys speaking during the 2025 PCPC Science Symposium & Expo

Industry Should Assume More Holistic, Integrated Approach To Animal Alternative Tests

 
• By Eileen Francis

Scientists at a session of the 2025 Personal Care Products Council’s Science Symposium & Expo on Oct. 28 emphasized that new approach methodologies for chemical safety testing should move beyond simple one-to-one animal test replacements toward integrated, holistic strategies.

FDA Position On Animal Alternative Sunscreen Tests Reflects ‘Troubling Disconnect’ – PETA

 
• By Lauren Nardella

The US Food and Drug Administration is advocating for the development of new alternative methods while specifying that animal tests are needed for sunscreen UV filters, creating uncertainty about the future of NAMs, say animal rights and industry groups.